Product Information
LORATADINE 5 MG/5 ML SYRUP is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.0405 per ML under NDC 51672208508. Its NADAC has been published 573 times since Nov 28, 2013.
FDA first approved this application on Aug 20, 2004.
Strength
5 mg/5mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672208508
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
LORATADINEApproval Type
Generic (ANDA)
FDA Application
ANDA076805FDA Approved
8/20/2004
On Market Since
8/20/2004
Price Statistics
The NADAC for LORATADINE 5 MG/5 ML SYRUP has been published 573 times since Nov 28, 2013, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0405 per ML |
|---|---|
| All-time high | $0.0471 (Dec 14, 2022) |
| All-time low | $0.0343 (Jul 17, 2024) |
| Median price | $0.0410 |
| Average price | $0.0410 |
| Largest weekly change | +25.7% (Aug 21, 2024) |
| Weeks tracked | 573 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-6.4%
5Y
+2.0%
All
-10.3%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORATADINE 5 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for LORATADINE 5 MG/5 ML SYRUP, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.0405 per ML (NDC 51672208508), effective Nov 13, 2024.
How has the price of LORATADINE 5 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for LORATADINE 5 MG/5 ML SYRUP has declined 10.3%. It has been tracked across 573 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LORATADINE 5 MG/5 ML SYRUP?
Since Nov 28, 2013, the NADAC for LORATADINE 5 MG/5 ML SYRUP has ranged from a low of $0.0343 (Jul 17, 2024) to a high of $0.0471 (Dec 14, 2022), with a median of $0.0410 per ML.
Are there cheaper alternatives to LORATADINE 5 MG/5 ML SYRUP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM CHILD LORATADINE 5 MG/5 ML, is $0.0370 per ML — about 9% below LORATADINE 5 MG/5 ML SYRUP.
Who manufactures LORATADINE 5 MG/5 ML SYRUP?
LORATADINE 5 MG/5 ML SYRUP (NDC 51672208508) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.